B Bian, NA Juiz, O Gayet, M Bigonnet… - Frontiers in …, 2019 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous disease, therefore stratification of patients is essential to predict their responses to therapies and to choose the …
VM Throm, D Männle, T Giese, AS Bauer, MM Gaida… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Smoking is associated with increased risk and poorer prognosis of pancreatic ductal adenocarcinoma (PDAC). Nicotine acts through cholinergic nicotinic receptors, preferentially …
M Neulinger-Muñoz, D Schaack, SP Grekova… - Viruses, 2021 - mdpi.com
Although the oncolytic parvovirus H-1PV has entered clinical trials, predicting therapeutic success remains challenging. We investigated whether the antiviral state in tumor cells …